Format

Send to

Choose Destination
Curr Opin Lipidol. 2016 Apr;27(2):162-71. doi: 10.1097/MOL.0000000000000276.

Metabolic syndrome: genetic insights into disease pathogenesis.

Author information

1
Department of Internal Medicine and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.

Abstract

PURPOSE OF REVIEW:

Metabolic syndrome (MetS) is a cluster of interrelated and heritable metabolic traits, which collectively impart unsurpassed risk for atherosclerotic cardiovascular disease and type 2 diabetes. Considerable work has been done to understand the underlying disease mechanisms by elucidating its genetic cause.

RECENT FINDINGS:

Genome-wide association studies have been widely utilized albeit with modest success in identifying variants that are associated with more than two metabolic traits. Another limitation of this approach is the inherent small effect of the common variants, a major barrier for dissecting their cognate pathways. Modest advances in this venue have been also made by genetic studies of kindreds at the extreme ends of quantitative distributions. These efforts have led to the discovery of a number of disease genes with large effects that underlie the association of diverse traits of this syndrome.

SUMMARY:

Substantial progress has been made over the last decade in identification of genetic risk factors associated with the various traits of MetS. The heterogeneity and multifactorial heritability of MetS, however, has been a challenge toward understanding the factors underlying the association of these traits. Genetic investigations of outlier kindreds or homogenous populations with high prevalence for the disease can potentially improve our knowledge of the disease pathophysiology.

PMID:
26825138
PMCID:
PMC5141383
DOI:
10.1097/MOL.0000000000000276
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center